Table 1. Trial demographics in 70 trials.

No. of randomly assigned patients per trial (median; range)	403 (126–1725)
Year of trial initiation (median; range)	2002 (1988–2007)
Publication type (full text/abstract form only)	55/15
Primary endpoint (OS/PFS)	47/23
Proportion of pts with ECOG PS of 0 and 1 (median; range)	96 (0–100)*

Abbreviations: OS  =  overall survival, PFS  =  progression-free survival, ECOG PS  =  Eastern Cooperative Oncology Group performance status.

*indicating the median score of proportion of good ECOG-PS patients in each eligible trial and its range.